Related Experiment Video
Updated: Aug 14, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
Sp3 is a transcriptional repressor of transforming growth factor-beta receptors
1Department of Surgery, University of Texas Health Science Center, San Antonio, Texas 78229, USA.
Abstract:
MCF-7E breast cancer cells express transforming growth factor-beta (TGF-beta) receptors RI and RII in comparison to MCF-7L cells. We present data showing that Sp3 acts as a transcriptional repressor of RI and RII in MCF-7L cells and GEO colon cancer cells. MCF-7L and GEO cells express high levels of Sp3 protein. Gel shift analysis indicated enhanced binding of Sp3 from MCF-7L cells to a consensus Sp1 oligonucleotide. Southwestern data indicated increased binding of Sp3 to RI and RII promoters in MCF-7L cells, suggesting a correlation between Sp3 binding and reduced expression of TGF-beta receptors in MCF-7L cells. Cotransfection of CMV-Sp3 cDNA with RI and RII promoter-luciferase reporter constructs decreased RI and RII promoter activities by 70% in MCF-7E and GEO cells. Southwestern analysis detected the binding of transiently expressed Sp3 to RI and RII promoters in MCF-7E cells. Significantly, ectopic Sp3 expression led to repression of RI and RII transcripts in MCF-7E cells. This report demonstrates that inappropriate overexpression of Sp3 is a mechanism that contributes to repression of TGF-beta receptors.
Insights
High Sp3 protein levels repress transforming growth factor-beta (TGF-beta) receptors RI and RII in cancer cells. This study reveals Sp3 overexpression as a mechanism contributing to TGF-beta receptor repression.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- MCF-7E breast cancer cells express TGF-beta receptors RI and RII, unlike MCF-7L cells.
- MCF-7L and GEO colon cancer cells exhibit high Sp3 protein levels.
Purpose of the Study:
- To investigate the role of Sp3 in regulating TGF-beta receptor expression in cancer cells.
- To determine if Sp3 acts as a transcriptional repressor of TGF-beta receptors RI and RII.
Main Methods:
- Gel shift and Southwestern analyses to assess Sp3 binding to DNA and promoters.
- Reporter gene assays (luciferase) to measure promoter activity.
- Analysis of TGF-beta receptor transcript levels following Sp3 expression.
Main Results:
- Sp3 protein from MCF-7L cells showed enhanced binding to Sp1 oligonucleotides and RI/RII promoters.
- Overexpression of Sp3 significantly decreased RI and RII promoter activity by 70% in MCF-7E and GEO cells.
- Ectopic Sp3 expression led to repression of RI and RII transcripts in MCF-7E cells.
Conclusions:
- Sp3 functions as a transcriptional repressor of TGF-beta receptors RI and RII.
- Inappropriate Sp3 overexpression is a mechanism contributing to the repression of TGF-beta receptors in cancer.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Transcription Factors
Co-activators and Co-repressors
Master Transcription Regulators
General Transcription Factors
TGF - β Signaling Pathway

